Myasoedova, Veronika A.

The impact of interferon-regulatory factors to macrophage differentiation and polarization into M1 and M2

Chistiakov, D. A., Myasoedova, V. A., Revin, V. V., Orekhov, A. N., & Bobryshev, Y. V. (2018) · Immunobiology

Immune cells in cancerinterferon and immune responses

Cited by 311

Efficacy of cardiometabolic drugs in reduction of epicardial adipose tissue: a systematic review and meta-analysis

Myasoedova, V. A., Parisi, V., Moschetta, D., Valerio, V., Conte, M., Massaiu, I., Bozzi, M., Celeste, F., Leosco, D., Iaccarino, G., et al. (2023) · Cardiovascular Diabetology

Cardiovascular Disease and AdiposityAdipokines, Inflammation, and Metabolic Diseases

Cited by 93

Inhibition of sialidase activity as a therapeutic approach

Glanz, V. Y., Myasoedova, V. A., Grechko, A. V., & Orekhov, A. N. (2018) · Drug Design Development and Therapy

Influenza Virus Research StudiesCarbohydrate Chemistry and Synthesis

Cited by 59

Anti-inflammation and anti-oxidation: the key to unlocking the cardiovascular potential of SGLT2 Inhibitors and GLP1 receptor agonists

Myasoedova, V. A., Bozzi, M., Valerio, V., Moschetta, D., Massaiu, I., Rusconi, V., Di Napoli, D., Ciccarelli, M., Parisi, V., Agostoni, P., et al. (2023) · Antioxidants

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 35

Sex-specific cell types and molecular pathways indicate fibro-calcific aortic valve stenosis

Myasoedova, V. A., Massaiu, I., Moschetta, D., Chiesa, M., Songia, P., Valerio, V., Alfieri, V., Capoulade, R., Trabattoni, D., Andreini, D., et al. (2022) · Frontiers in Immunology

Cardiac Valve Diseases and TreatmentsAortic Disease and Treatment Approaches

Cited by 32